Daunorubicin and gambogic acid coloaded cysteamine-CdTe quantum dots minimizing the multidrug resistance of lymphoma in vitro and in vivo

Yi Zhou,1,2 Ruju Wang,1 Bing Chen,1 Dan Sun,3 Yong Hu,2 Peipei Xu1 1Department of Hematology, Drum Tower Hospital, School of Medicine, 2Institute of Materials Engineering and Collaborative Innovation Center of Chemistry for Life Sciences, College of Engineering and Applied Sciences, Nanjing Univers...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Zhou Y, Wang R, Chen B, Sun D, Hu Y, Xu P
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	daunorubicin gambogic acid Cys-CdTe QDs multidrug resistance non-Hodgkin lymphoma Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/c981a089b10e459c994338830a5972c9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:c981a089b10e459c994338830a5972c9
record_format	dspace
spelling	oai:doaj.org-article:c981a089b10e459c994338830a5972c92021-12-02T00:31:22ZDaunorubicin and gambogic acid coloaded cysteamine-CdTe quantum dots minimizing the multidrug resistance of lymphoma in vitro and in vivo1178-2013https://doaj.org/article/c981a089b10e459c994338830a5972c92016-10-01T00:00:00Zhttps://www.dovepress.com/daunorubicin-and-gambogic-acid-coloaded-cysteamine-cdte-quantum-dots-m-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Yi Zhou,1,2 Ruju Wang,1 Bing Chen,1 Dan Sun,3 Yong Hu,2 Peipei Xu1 1Department of Hematology, Drum Tower Hospital, School of Medicine, 2Institute of Materials Engineering and Collaborative Innovation Center of Chemistry for Life Sciences, College of Engineering and Applied Sciences, Nanjing University, Nanjing People’s Republic of China; 3School of Mechanical Engineering, Queen’s University Belfast, Belfast, UK Abstract: To minimize the side effects and the multidrug resistance (MDR) arising from daunorubicin (DNR) treatment of malignant lymphoma, a chemotherapy formulation of cysteamine-modified cadmium tellurium (Cys-CdTe) quantum dots coloaded with DNR and gambogic acid (GA) nanoparticles (DNR-GA-Cys-CdTe NPs) was developed. The physical property, drug-loading efficiency and drug release behavior of these DNR-GA-Cys-CdTe NPs were evaluated, and their cytotoxicity was explored by 3-[4,5-dimethylthiazol-2-y1]-2,5-diphenyltetrazolium bromide assay. These DNR-GA-Cys-CdTe NPs possessed a pH-responsive behavior, and displayed a dose-dependent antiproliferative activity on multidrug-resistant lymphoma Raji/DNR cells. The accumulation of DNR inside the cells, revealed by flow cytometry assay, and the down-regulated expression of P-glycoprotein inside the Raji/DNR cells measured by Western blotting assay indicated that these DNR-GA-Cys-CdTe NPs could minimize the MDR of Raji/DNR cells. This multidrug delivery system would be a promising strategy for minimizing MDR against the lymphoma. Keywords: daunorubicin, gambogic acid, Cys-CdTe QDs, multidrug resistance, non-Hodgkin’s lymphomaZhou YWang RChen BSun DHu YXu PDove Medical Pressarticledaunorubicingambogic acidCys-CdTe QDsmultidrug resistancenon-Hodgkin lymphomaMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 11, Pp 5429-5442 (2016)
institution	DOAJ
collection	DOAJ
language	EN
topic	daunorubicin gambogic acid Cys-CdTe QDs multidrug resistance non-Hodgkin lymphoma Medicine (General) R5-920
spellingShingle	daunorubicin gambogic acid Cys-CdTe QDs multidrug resistance non-Hodgkin lymphoma Medicine (General) R5-920 Zhou Y Wang R Chen B Sun D Hu Y Xu P Daunorubicin and gambogic acid coloaded cysteamine-CdTe quantum dots minimizing the multidrug resistance of lymphoma in vitro and in vivo
description	Yi Zhou,1,2 Ruju Wang,1 Bing Chen,1 Dan Sun,3 Yong Hu,2 Peipei Xu1 1Department of Hematology, Drum Tower Hospital, School of Medicine, 2Institute of Materials Engineering and Collaborative Innovation Center of Chemistry for Life Sciences, College of Engineering and Applied Sciences, Nanjing University, Nanjing People’s Republic of China; 3School of Mechanical Engineering, Queen’s University Belfast, Belfast, UK Abstract: To minimize the side effects and the multidrug resistance (MDR) arising from daunorubicin (DNR) treatment of malignant lymphoma, a chemotherapy formulation of cysteamine-modified cadmium tellurium (Cys-CdTe) quantum dots coloaded with DNR and gambogic acid (GA) nanoparticles (DNR-GA-Cys-CdTe NPs) was developed. The physical property, drug-loading efficiency and drug release behavior of these DNR-GA-Cys-CdTe NPs were evaluated, and their cytotoxicity was explored by 3-[4,5-dimethylthiazol-2-y1]-2,5-diphenyltetrazolium bromide assay. These DNR-GA-Cys-CdTe NPs possessed a pH-responsive behavior, and displayed a dose-dependent antiproliferative activity on multidrug-resistant lymphoma Raji/DNR cells. The accumulation of DNR inside the cells, revealed by flow cytometry assay, and the down-regulated expression of P-glycoprotein inside the Raji/DNR cells measured by Western blotting assay indicated that these DNR-GA-Cys-CdTe NPs could minimize the MDR of Raji/DNR cells. This multidrug delivery system would be a promising strategy for minimizing MDR against the lymphoma. Keywords: daunorubicin, gambogic acid, Cys-CdTe QDs, multidrug resistance, non-Hodgkin’s lymphoma
format	article
author	Zhou Y Wang R Chen B Sun D Hu Y Xu P
author_facet	Zhou Y Wang R Chen B Sun D Hu Y Xu P
author_sort	Zhou Y
title	Daunorubicin and gambogic acid coloaded cysteamine-CdTe quantum dots minimizing the multidrug resistance of lymphoma in vitro and in vivo
title_short	Daunorubicin and gambogic acid coloaded cysteamine-CdTe quantum dots minimizing the multidrug resistance of lymphoma in vitro and in vivo
title_full	Daunorubicin and gambogic acid coloaded cysteamine-CdTe quantum dots minimizing the multidrug resistance of lymphoma in vitro and in vivo
title_fullStr	Daunorubicin and gambogic acid coloaded cysteamine-CdTe quantum dots minimizing the multidrug resistance of lymphoma in vitro and in vivo
title_full_unstemmed	Daunorubicin and gambogic acid coloaded cysteamine-CdTe quantum dots minimizing the multidrug resistance of lymphoma in vitro and in vivo
title_sort	daunorubicin and gambogic acid coloaded cysteamine-cdte quantum dots minimizing the multidrug resistance of lymphoma in vitro and in vivo
publisher	Dove Medical Press
publishDate	2016
url	https://doaj.org/article/c981a089b10e459c994338830a5972c9
work_keys_str_mv	AT zhouy daunorubicinandgambogicacidcoloadedcysteaminecdtequantumdotsminimizingthemultidrugresistanceoflymphomainvitroandinvivo AT wangr daunorubicinandgambogicacidcoloadedcysteaminecdtequantumdotsminimizingthemultidrugresistanceoflymphomainvitroandinvivo AT chenb daunorubicinandgambogicacidcoloadedcysteaminecdtequantumdotsminimizingthemultidrugresistanceoflymphomainvitroandinvivo AT sund daunorubicinandgambogicacidcoloadedcysteaminecdtequantumdotsminimizingthemultidrugresistanceoflymphomainvitroandinvivo AT huy daunorubicinandgambogicacidcoloadedcysteaminecdtequantumdotsminimizingthemultidrugresistanceoflymphomainvitroandinvivo AT xup daunorubicinandgambogicacidcoloadedcysteaminecdtequantumdotsminimizingthemultidrugresistanceoflymphomainvitroandinvivo
_version_	1718403706566737920

Daunorubicin and gambogic acid coloaded cysteamine-CdTe quantum dots minimizing the multidrug resistance of lymphoma in vitro and in vivo

Ejemplares similares